The CDC and FDA AR Isolate Bank will provide information to LexaGene which will support the company’s diagnostics development and help address the serious issue of antibiotic resistance.
![fc9eaf08-5d8b-4c20-a73c-516188a3e81a-e1565209824158[1]](https://lexagene.com/wp-content/uploads/2021/11/fc9eaf08-5d8b-4c20-a73c-516188a3e81a-e15652098241581.jpeg)
BioSpace article on LexaGene antibiotic resistance testing
LexaGene
LexaGene develops fully automated, rapid molecular testing at the point-of-need for accurate pathogen detection in human clinical diagnostics, veterinary diagnostics, food safety, and other markets.
Upcoming Events
No events in this category to show at this time.
Latest Resources
LexaGene’s MiQLab™ System, a TRL-7 technology, drastically shortens the time gap between novel pathogen identification and point-of-need testing through its open-access feature.